It will be important to investigate how ERBB family members contribute to CC cancer progression in more detail to identify unpredicted functions of this protein family and to develop potential therapeutic strategies with other conventional therapeutic agents for expanding clinical trials. The gene discussed is EGFR; the disease is cholangiocarcinoma.